Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. The Company has five segments: Pharmaceuticals, which include patent-protected prescription medicines; Alcon, which include surgical, ophthalmic pharmaceutical and vision care products; Sandoz, which include generic pharmaceuticals; vaccines and diagnostics, which include human vaccines and blood-testing diagnostics, and consumer health, which include over-the-counter medicines (OTC) and Animal Health. On April 8, 2011, the Company acquired the remaining non-controlling interest in Alcon, Inc.
BASEL, Switzerland 4056
|Chairman of the Board of Directors||Daniel Vasella|
|Chief Executive Officer, Member of the Executive Committee||Joseph Jimenez|
|Vice Chairman of the Board of Directors, Non-Executive Director||Ulrich Lehner|
|Chief Financial Officer, Member of the Executive Committee||Jonathan Symonds|
|Group General Counsel, Member of the Executive Committee||Felix Ehrat|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||2.7B||Book Value||$28.54|
|Annual Dividend Rate||$1.58||Price/Sales (TTM)||3.5|
|Ex-Div Date||2/26/13||P/Cash Flow (TTM)||14.1x|
|Pay Date||2/26/14||Operating Margin||20.04%|
*GAAP = prior to non-GAAP analyst adjusted earnings.